Showing 1 to 2 of 2 Clinical Trials
|
CLINICAL TRIAL Trial No ClinicalTrials.gov ID |
Principal Investigator
Coordinator |
||
|---|---|---|---|
|
Phase 3 Randomized, Controlled Study of Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia With Safety Run-in
Golden Gate Study NCT04994717  Recruiting
|
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
|
Acute Lymphocytic Leukemia |
Dr. Julie Bergeron Julie Trinh Lu 514-252-3400 poste 3336 Michel-Olivier Gratton 514-252-3400 poste 2397 |
|
A Phase 2 Study of Blinatumomab in Combination With Nivolumab, a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged ? 1 to < 31 Years Old With First Relapse
COG-AALL1821 NCT04546399  Temporary interruption
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
|
Acute Lymphocytic Leukemia |
Dr. Yvan Samson |
Groupe d'étude en oncologie du Québec